ENDRA Life Sciences (NDRA) Profit After Tax (2016 - 2021)
Historic Profit After Tax for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$3.1 million.
- ENDRA Life Sciences' Profit After Tax fell 3793.68% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 421.52%. This contributed to the annual value of -$11.5 million for FY2024, which is 1439.03% down from last year.
- Per ENDRA Life Sciences' latest filing, its Profit After Tax stood at -$3.1 million for Q4 2021, which was down 3793.68% from -$2.7 million recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' Profit After Tax registered a high of -$741623.0 during Q1 2017, and its lowest value of -$4.8 million during Q4 2019.
- Its 5-year average for Profit After Tax is -$2.6 million, with a median of -$2.7 million in 2019.
- As far as peak fluctuations go, ENDRA Life Sciences' Profit After Tax plummeted by 28096.22% in 2018, and later skyrocketed by 5319.98% in 2020.
- Over the past 5 years, ENDRA Life Sciences' Profit After Tax (Quarter) stood at -$2.3 million in 2017, then fell by 3.09% to -$2.4 million in 2018, then tumbled by 103.3% to -$4.8 million in 2019, then skyrocketed by 53.2% to -$2.3 million in 2020, then plummeted by 37.94% to -$3.1 million in 2021.
- Its Profit After Tax was -$3.1 million in Q4 2021, compared to -$2.7 million in Q3 2021 and -$3.2 million in Q2 2021.